Janux Therapeutics (JANX) had the highest return between February 13, 2024 and March 1, 2024 by a US stock with a market cap of $1B+, returning 492.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Janux Therapeutics (JANX) | 2/13/2024 - 3/1/2024 | 492.91% |
Root (ROOT) | 2/13/2024 - 3/1/2024 | 378.12% |
SoundHound AI (SOUN) | 2/13/2024 - 3/1/2024 | 186.02% |
Viking Therapeutics (VKTX) | 2/13/2024 - 3/1/2024 | 182% |
Jumia Technologies (JMIA) | 2/13/2024 - 3/1/2024 | 115.26% |
GeneDx (WGS) | 2/13/2024 - 3/1/2024 | 108.82% |
BigBearai (BBAI) | 2/13/2024 - 3/1/2024 | 91.16% |
Taysha Gene Therapies (TSHA) | 2/13/2024 - 3/1/2024 | 91.12% |
Arcutis Biotherapeutics (ARQT) | 2/13/2024 - 3/1/2024 | 88.32% |
Acm Research (ACMR) | 2/13/2024 - 3/1/2024 | 88.18% |
Ocular Therapeutix (OCUL) | 2/13/2024 - 3/1/2024 | 86.31% |
Sana Biotechnology (SANA) | 2/13/2024 - 3/1/2024 | 73.65% |
Trevi Therapeutics (TRVI) | 2/13/2024 - 3/1/2024 | 65.54% |
Stoke Therapeutics (STOK) | 2/13/2024 - 3/1/2024 | 60.63% |
Carvana (CVNA) | 2/13/2024 - 3/1/2024 | 60.5% |
MicroStrategy (MSTR) | 2/13/2024 - 3/1/2024 | 59.91% |
PureCycle Technologies (PCTTW) | 2/13/2024 - 3/1/2024 | 49.82% |
Krystal Biotech (KRYS) | 2/13/2024 - 3/1/2024 | 49.17% |
Coinbase Global (COIN) | 2/13/2024 - 3/1/2024 | 48.69% |
Dell Technologies (DELL) | 2/13/2024 - 3/1/2024 | 46.6% |
Now (DNOW) | 2/13/2024 - 3/1/2024 | 46.59% |
Li Auto (LI) | 2/13/2024 - 3/1/2024 | 46.16% |
Avidity Biosciences (RNA) | 2/13/2024 - 3/1/2024 | 45.83% |
Adapthealth (AHCO) | 2/13/2024 - 3/1/2024 | 45.3% |
TheRealReal (REAL) | 2/13/2024 - 3/1/2024 | 44.5% |
